eye disease: A non-neoplastic or neoplastic disorder that affects the eye. Representative examples include conjunctivitis, glaucoma, cataract, conjunctival squamous cell carcinoma, uveal melanoma, and retinoblastoma. [NCIt:C26767]
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
---|---|
Phenotype data |
473681 |
1. Apply sex-specific ruleNone |
473681 |
2. Check conditionsNone |
473681 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
19427 |
4. Check minimum number of eventsNone |
19427 |
5. Include endpoints |
19550 |
6. Filter based on genotype QC (FinnGen only) |
18951 |
Control definitions (FinnGen only)
Extra metadata
Similar endpoints
↥List of similar endpoints to Disorders of vitreous body based on the number of shared cases.
Similar with more cases:
- Disorders of vitreous body and globe
- Diseases of the eye and adnexa
- Any event in hilmo or specialist outpatient
Similar with less cases:
Case counts by codes
↥Summary Statistics
↥-FinRegistry-
Key figures
All | Female | Male | |
---|---|---|---|
Number of individuals | |||
Whole population | 127368 | 79793 | 47138 |
Only index persons | 121972 | 77369 | 44603 |
Unadjusted period prevalence (%) | |||
Whole population | 1.92 | 2.29 | 1.32 |
Only index persons | 2.43 | 2.84 | 1.70 |
Median age at first event (years) | |||
Whole population | 63.96 | 63.44 | 64.88 |
Only index persons | 63.84 | 63.30 | 64.77 |
-FinnGen-
Key figures
All | Female | Male | |
---|---|---|---|
Number of individuals | 18951 | 11982 | 6969 |
Unadjusted period prevalence (%) | 4.26 | 4.71 | 3.50 |
Median age at first event (years) | 63.50 | 62.33 | 65.52 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
Mortality – FinRegistry
↥Association
Association between endpoint H7_VITRBODYGLOBE and mortality.
Females
Parameter | HR [95% CI] | p-value |
---|---|---|
H7_VITRBODYGLOBE | 0.937 [0.86, 1.02] | 0.152 |
Birth year | 0.995 [0.99, 1.0] | 0.198 |
During the follow-up period (1.1.1998 — 31.12.2019), 7860 out of 66146 females with H7_VITRBODYGLOBE died.
Males
Parameter | HR [95% CI] | p-value |
---|---|---|
H7_VITRBODYGLOBE | 1.008 [0.92, 1.11] | 0.868 |
Birth year | 0.987 [0.98, 1.0] | 0.004 |
During the follow-up period (1.1.1998 — 31.12.2019), 7188 out of 38411 males with H7_VITRBODYGLOBE died.
Mortality risk
Mortality risk for people of age
years, who have H7_VITRBODYGLOBE.N-year risk | Females | Males |
---|---|---|
1 | 0.09% | 0.178% |
5 | 0.561% | 1.071% |
10 | 1.298% | 2.785% |
15 | 2.644% | 5.137% |
20 | 4.601% | 9.052% |
Relationships between endpoints
↥Index endpoint: H7_VITRBODYGLOBE – Disorders of vitreous body
GWS hits: 3